Can-Fite BioPharma (CANF) Non-Current Deffered Revenue (2015 - 2026)
Can-Fite BioPharma (CANF) recorded Non-Current Deffered Revenue of $974,000 in Q2 2026, down 29.6% from $1.38 million a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Non-Current Deffered Revenue (2015 - 2026) Analysis & Trends
At the end of FY2025, Can-Fite BioPharma reported Non-Current Deffered Revenue of $1.18 million, down 25.6% from FY2024.
- Annual Non-Current Deffered Revenue has declined for four straight years, with a five-year compound annual growth rate of -11.4% (FY2020 to FY2025).
- Across earlier years, Non-Current Deffered Revenue came in at $1.58 million in FY2024 (-7.7%), $1.71 million in FY2023 (-25.4%), $2.3 million in FY2022 (-25.2%) and $3.07 million in FY2021 (+42.4%).
- The Q2 2026 figure is the lowest quarterly Non-Current Deffered Revenue since Q4 2017.
- Peak year-over-year performance for Non-Current Deffered Revenue in the last five years was growth of 58.4% in Q3 2021, against a decline of 30.5% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - | 974,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 974,000.00 |
| Dec 31, 2025 | 1.18 Mn |
| Jun 30, 2025 | 1.38 Mn |
| Dec 31, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.71 Mn |
| Jun 30, 2023 | 1.90 Mn |
| Mar 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 2.46 Mn |
| Jun 30, 2022 | 2.66 Mn |
| Mar 31, 2022 | 2.87 Mn |
| Dec 31, 2021 | 3.07 Mn |
| Sep 30, 2021 | 3.09 Mn |
| Jun 30, 2021 | 3.34 Mn |
| Mar 31, 2021 | 3.59 Mn |
| Dec 31, 2020 | 2.16 Mn |
| Sep 30, 2020 | 1.95 Mn |
| Jun 30, 2020 | 2.12 Mn |
API Access
Can-Fite BioPharma Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();